55 related articles for article (PubMed ID: 23749480)
1. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?
Chen C; Lin X; Pan J; Fei Z; Chen L; Bai P
Jpn J Radiol; 2013 Sep; 31(9):593-9. PubMed ID: 23749480
[TBL] [Abstract][Full Text] [Related]
2. Anatomical changes and dosimetric analysis of the neck region based on FBCT for nasopharyngeal carcinoma patients during radiotherapy.
Chen A; Chen X; Jiang X; Wang Y; Chi F; Xie D; Zhou M
J Xray Sci Technol; 2024; 32(3):783-795. PubMed ID: 38457140
[TBL] [Abstract][Full Text] [Related]
3. Automatic IMRT treatment planning through fluence prediction and plan fine-tuning for nasopharyngeal carcinoma.
Cai W; Ding S; Li H; Zhou X; Dou W; Zhou L; Song T; Li Y
Radiat Oncol; 2024 Mar; 19(1):39. PubMed ID: 38509540
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: improvement of the therapeutic ratio with helical tomotherapy vs segmental multileaf collimator-based techniques.
Chen AM; Yang CC; Marsano J; Liu T; Purdy JA
Br J Radiol; 2012 Aug; 85(1016):e537-43. PubMed ID: 22253350
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning-Based Prediction of Radiation Therapy Dose Distributions in Nasopharyngeal Carcinomas: A Preliminary Study Incorporating Multiple Features Including Images, Structures, and Dosimetry.
Wang Y; Piao Z; Gu H; Chen M; Zhang D; Zhu J
Technol Cancer Res Treat; 2024; 23():15330338241256594. PubMed ID: 38808514
[No Abstract] [Full Text] [Related]
6. Comparison of 3D anatomical dose verification and 2D phantom dose verification of IMRT/VMAT treatments for nasopharyngeal carcinoma.
Lin H; Huang S; Deng X; Zhu J; Chen L
Radiat Oncol; 2014 Mar; 9():71. PubMed ID: 24606879
[TBL] [Abstract][Full Text] [Related]
7. Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China.
Zhou X; Zhu J; Zhou C; Wang W; Ding W; Chen M; Chen K; Li S; Chen X; Yang H
Radiat Oncol; 2023 Nov; 18(1):190. PubMed ID: 37974274
[TBL] [Abstract][Full Text] [Related]
8. A Neural Network-based Method for Predicting Dose to Organs at Risk in Intensity-modulated Radiotherapy for Nasopharyngeal Carcinoma.
Zhang HW; Pang HW; Wang YH; Jiang W
Clin Oncol (R Coll Radiol); 2024 Jan; 36(1):46-55. PubMed ID: 37996310
[TBL] [Abstract][Full Text] [Related]
9. Early evaluation of radiation-induced parotid damage in patients with nasopharyngeal carcinoma by T2 mapping and mDIXON Quant imaging: initial findings.
Zhou N; Chu C; Dou X; Chen W; He J; Yan J; Zhou Z; Yang X
Radiat Oncol; 2018 Feb; 13(1):22. PubMed ID: 29422068
[TBL] [Abstract][Full Text] [Related]
10. Recommendation regarding the cranial upper border of level IIb in delineating clinical target volumes (CTV) for nasopharyngeal carcinoma.
Wang L; Huang S; Zhang L; He X; Liu Y
Radiat Oncol; 2020 Nov; 15(1):270. PubMed ID: 33228742
[TBL] [Abstract][Full Text] [Related]
11. Wearing individualized 3D printed oral stent to protect normal tissues in patients with nasopharyngeal carcinoma during radiotherapy.
Yang W; Yang Z; Pan W; Li H; Zhao T; Meng Y; Ma G; Ye H; Shang J
J Appl Clin Med Phys; 2023 Dec; 24(12):e14145. PubMed ID: 37676885
[TBL] [Abstract][Full Text] [Related]
12. Comparison of magnetic resonance imaging and CT scan-based delineation of target volumes and organs at risk in the radiation treatment planning of head and neck malignancies.
R L; Gupta M; Gupta S; Joseph D; Krishnan AS; Sharma P; Verma S; Mandal S; R S N
J Med Imaging Radiat Sci; 2023 Sep; 54(3):503-510. PubMed ID: 37164871
[TBL] [Abstract][Full Text] [Related]
13. Correlation between hippocampal radiation doses and psychological condition for patients with stage T1-2 nasopharyngeal carcinoma.
Gai X; Su L; Huang S; Zeng J; Guo F; Cai C; Lv W; Liu F; Li S; Hong J
Radiother Oncol; 2023 Dec; 189():109942. PubMed ID: 37813310
[TBL] [Abstract][Full Text] [Related]
14. Cranial organs at risk delineation: heterogenous practices in radiotherapy planning.
Vogin G; Hettal L; Bartau C; Thariat J; Claeys MV; Peyraga G; Retif P; Schick U; Antoni D; Bodgal Z; Dhermain F; Feuvret L
Radiat Oncol; 2021 Feb; 16(1):26. PubMed ID: 33541394
[TBL] [Abstract][Full Text] [Related]
15. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma.
Lee AW; Ng WT; Pan JJ; Chiang CL; Poh SS; Choi HC; Ahn YC; AlHussain H; Corry J; Grau C; Grégoire V; Harrington KJ; Hu CS; Kwong DL; Langendijk JA; Le QT; Lee NY; Lin JC; Lu TX; Mendenhall WM; O'Sullivan B; Ozyar E; Peters LJ; Rosenthal DI; Sanguineti G; Soong YL; Tao Y; Yom SS; Wee JT
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):567-580. PubMed ID: 31276776
[TBL] [Abstract][Full Text] [Related]
16. Hypoglossal nerve delineation in nasopharyngeal carcinoma patients may reduce the radiation dose and damage to the nerve.
Chen F; Jen YM; He K; Yin ZS; Lee JC; Huang WY; Tang YH
Med Dosim; 2024 Summer; 49(2):102-108. PubMed ID: 37858458
[TBL] [Abstract][Full Text] [Related]
17. Adaptive Proton Therapy for Pediatric Parameningeal Rhabdomyosarcoma: On-Treatment Anatomic Changes and Timing to Replanning.
Uh J; Jordan JA; Pappo AS; Krasin MJ; Hua C
Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):245-254. PubMed ID: 36764878
[TBL] [Abstract][Full Text] [Related]
18. Improved prediction of radiation-induced hypothyroidism in nasopharyngeal carcinoma using pre-treatment CT radiomics.
Ritlumlert N; Wongwattananard S; Prayongrat A; Oonsiri S; Kitpanit S; Kannarunimit D; Chakkabat C; Lertbutsayanukul C; Sriswasdi S; Rakvongthai Y
Sci Rep; 2023 Oct; 13(1):17437. PubMed ID: 37838730
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma.
Chen YP; Chan ATC; Le QT; Blanchard P; Sun Y; Ma J
Lancet; 2019 Jul; 394(10192):64-80. PubMed ID: 31178151
[TBL] [Abstract][Full Text] [Related]
20. Dosimetrically triggered adaptive radiotherapy for head and neck cancer: Considerations for the implementation of clinical protocols.
Barragán-Montero AM; Van Ooteghem G; Dumont D; Rivas ST; Sterpin E; Geets X
J Appl Clin Med Phys; 2023 Nov; 24(11):e14095. PubMed ID: 37448193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
